User profiles for O. Delattre

Olivier Delattre

Inserm-Institut Curie
Verified email at curie.fr
Cited by 56242

[PDF][PDF] Ewing sarcoma: current management and future approaches through collaboration

…, H Kovar, R Grimer, J Whelan, L Claude, O Delattre… - J Clin …, 2015 - researchgate.net
… Schleiermacher G, Delattre O: Detection of micrometastases and circulating tumour cells
using molecular biology technics in solid tumours [in French]. Bull Cancer 88:561-570, 2001 47. …

Ewing sarcoma

…, H Kovar, PH Sorensen, O Delattre… - Nature reviews Disease …, 2018 - nature.com
Ewing sarcoma is the second most frequent bone tumour of childhood and adolescence that
can also arise in soft tissue. Ewing sarcoma is a highly aggressive cancer, with a survival of …

SWI/SNF chromatin remodeling and human malignancies

…, F Bourdeaut, O Delattre - Annual Review of …, 2015 - annualreviews.org
The SWI/SNF complexes, initially identified in yeast 20 years ago, are a family of multi-subunit
complexes that use the energy of adenosine triphosphate (ATP) hydrolysis to remodel …

Systematic identification of genomic markers of drug sensitivity in cancer cells

…, I Stamenkovic, JA Engelman, SV Sharma, O Delattre… - Nature, 2012 - nature.com
Clinical responses to anticancer therapies are often restricted to a subset of patients. In some
cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here…

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

O Delattre, J Zucman, B Plougastel, C Desmaze… - Nature, 1992 - nature.com
EWING'S sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent
and specific t(ll;22) (q24;q12) chromosome translocation 1–8 , the breakpoints of which …

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

…, P Jong, D Parry, R Eldrige, A Aurias, O Delattre… - Nature, 1993 - nature.com
… radixin: a large N-terminal domain followed by a large o-helix domain and a small C terminus.
… From these homologies we predict that the N-terminal domain binds to integrins and the o- …

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

…, P Ambros, R Handgretinger, A Aurias, O Delattre - Nature, 1998 - nature.com
Malignant rhabdoid tumours (MRTs) are extremely aggressive cancers of early childhood.
They can occur in various locations, mainly the kidney, brain and soft tissues 1 , 2 . …

[HTML][HTML] Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and …

…, ML Bäcklund, C Haberler, F Bourdeaut, O Delattre… - Acta …, 2012 - Springer
Medulloblastoma is the most common malignant brain tumor in childhood. Molecular studies
from several groups around the world demonstrated that medulloblastoma is not one …

[HTML][HTML] Subgroup-specific structural variation across 1,000 medulloblastoma genomes

…, M Perek-Polnik, CC Haberler, O Delattre… - Nature, 2012 - nature.com
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated
with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive …

[PDF][PDF] Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition

…, S Croul, G Zadeh, JO Korbel, F Doz, O Delattre… - Cancer cell, 2014 - cell.com
Smoothened (SMO) inhibitors recently entered clinical trials for sonic-hedgehog-driven
medulloblastoma (SHH-MB). Clinical response is highly variable. To understand the mechanism(…